Radisavljevic Mirjana M, Bjelakovic Goran B, Nagorni Aleksandar V, Stojanovic Miroslav P, Radojkovicn Milan D, Jovic Jasna Z, Ignjatovic Aleksandra M, Radisavljevic Misa M, Simonovic Maja M
Department of Gastroenterology, Clinical Center of Nis, Nis, Serbia.
Med Princ Pract. 2017;26(2):169-175. doi: 10.1159/000451057. Epub 2016 Sep 27.
To identify the prognostic score that is the best predictor of outcome in patients hospitalized with decompensated liver cirrhosis.
In this prospective study, 126 patients were enrolled and followed up for 29 months. For each patient, prognostic scores were calculated; these included the Child-Turcotte-Pugh score (CTP score), CTP creatinine-modified I score, CTP creatinine-modified II score, Model for End-Stage Liver Disease (MELD score), MELD model for end-stage liver disease sodium-modified score, Integrated MELD score, updated MELD score, United Kingdom MELD, and the MELD score remodeled by serum sodium index (MESO index). Cox regression analysis was used to assess the ability of each of the scores for predicting mortality in patients with alcoholic cirrhosis. Their discriminatory ability was evaluated using receiver operating characteristic (ROC) curve analysis.
The updated MELD score had the highest predictive value (3.29) among the tested scores (95% CI: 2.26-4.78). ROC curve analysis demonstrated that the MELD score of 22.50 (AUC = 0.914, 95% CI: 0.849-0.978; p < 0.001) had the best discriminative ability for identifying patients with a high risk of mortality; the next best was the MESO index of 16.00 (AUC = 0.912, 95% CI: 0.847-0.978; p < 0.001).
The risk of mortality was highest in patients with the highest updated MELD score, and those with MELD scores >22.50 and a MESO index >16.00.
确定能最佳预测失代偿期肝硬化住院患者预后的预后评分。
在这项前瞻性研究中,纳入了126例患者并随访29个月。为每位患者计算预后评分;这些评分包括Child-Turcotte-Pugh评分(CTP评分)、CTP肌酐修正I评分、CTP肌酐修正II评分、终末期肝病模型(MELD评分)、终末期肝病模型钠修正评分、综合MELD评分、更新的MELD评分、英国MELD评分以及血清钠指数重塑的MELD评分(MESO指数)。采用Cox回归分析评估各评分预测酒精性肝硬化患者死亡率的能力。使用受试者工作特征(ROC)曲线分析评估其鉴别能力。
在测试的评分中,更新的MELD评分具有最高的预测价值(3.29)(95%可信区间:2.26 - 4.78)。ROC曲线分析表明,MELD评分为22.50(AUC = 0.914,95%可信区间:0.849 - 0.978;p < 0.001)对识别高死亡风险患者具有最佳鉴别能力;其次是MESO指数为16.00(AUC = 0.912,95%可信区间:0.847 - 0.978;p < 0.001)。
更新的MELD评分最高的患者以及MELD评分>22.50且MESO指数>16.00的患者死亡风险最高。